Difference between revisions of "US KS Kansas City Wilkins H"

Latest revision as of 11:24, 4 October 2021

US KS Kansas City Wilkins H

O2k-Network Lab	Hemenway at University of Kansas Medical Center, Department of Neurology, University of Kansas Alzheimer’s Disease Center
Address	2106 Olathe Blvd Bldg 64 Room 1039, 66109
City	Kansas City
State/Prov	Kansas (KS)
Country	USA
Weblink
Contact	Wilkins Heather M
Team
Team previous
Status	O2k 2019-
Oroboros Events
Topics	Alzheimer’s Disease, brain bioenergetics

	Published	Reference
Taylor 2024 Pilot Feasibility Stud	2024	Taylor MK, Burns JM, Choi IY, Herda TJ, Lee P, Smith AN, Sullivan DK, Swerdlow RH, Wilkins HM (2024) Protocol for a single-arm, pilot trial of creatine monohydrate supplementation in patients with Alzheimer's disease. Pilot Feasibility Stud 10:42. https://doi.org/10.1186/s40814-024-01469-5
Tungtur 2021 Sci Rep	2021	Tungtur SK, Wilkins HM, Rogers RS, Badawi Y, Sage JM, Agbas A, Jawdat O, Barohn RJ, Swerdlow RH, Nishimune H (2021) Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Sci Rep 11:11051.

update please

@@ Line 1: / Line 1: @@
 {{O2k-Network Lab
-|institution=Hemenway at University of Kansas Medical Center,
+|institution=Hemenway at University of Kansas Medical Center, Department of Neurology, University of Kansas Alzheimer’s Disease Center
-Department of Neurology,
-University of Kansas Alzheimer’s Disease Center
 |address=2106 Olathe Blvd Bldg 64 Room 1039
 |area code=66109
@@ Line 10: / Line 6: @@
 |state=Kansas (KS)
 |country=USA
-|Contact=Wilkins Heather M,
+|Contact=Wilkins Heather M
 |Status=O2k 2019-
+|keyword=Alzheimer’s Disease, brain bioenergetics
 }}